Taken together, this study demonstrates that PF can function as an antitumor agent for glioma treatment by targeting NEDD4L-dependent STAT3 ubiquitination as well as by regulating the Nrf2/GPX4 signaling axis, which might trigger ferroptosis. The gene discussed is GPX4; the disease is glioma.